Drug guidance
Second-generation antipsychotic injections for treating schizophrenia
Condition
Mental Health and Behaviour
1 October 2018
Published on 01 Oct 2018
Last Updated on 01 Oct 2018
Guidance Recommendations
The Ministry of Health’s Drug Advisory Committee has not recommended listing paliperidone or aripiprazole injections on the Medication Assistance Fund (MAF) for treating schizophrenia, due to unacceptable cost-effectiveness compared with first-generation antipsychotic injections at the prices proposed by the manufacturers.